CP and Ebola hemorrhagic fever: During the treatment of Ebola, any such use should be scientifically analyzed through research studies, and if CP and convalescent whole blood are to be used outside the confines of research studies, this should be considered as ‘monitored emergency use of unregistered and experimental interventions’, which was a term previously coined by the WHO during the Ebola outbreak in 2014.